Form 4: agilon health Director Ronald Williams Awarded RSUs

Director Ronald A. Williams received 2,133 restricted stock units following the company's recent 1-for-25 reverse stock split.

Summary

• Ronald A. Williams, a Director at agilon health, inc. (AGL), was granted 2,133 restricted stock units (RSUs) on June 2, 2026.
• The RSUs are scheduled to vest in full on June 2, 2027, provided the reporting person continues their service as a director.
• Following this transaction, Williams beneficially owns a total of 149,141 shares of common stock.
• A 1-for-25 reverse stock split was executed on March 30, 2026, which adjusted the total share count and is reflected in the current ownership figures.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing typical of corporate governance and director compensation cycles.

Positives

• Director interests remain aligned with shareholders through equity-based compensation.
• The reporting person maintains a significant stake of 149,141 shares in the company, indicating long-term commitment.

Negatives

• The 1-for-25 reverse stock split effective March 30, 2026, typically indicates historical downward pressure on the share price or a need to meet exchange listing requirements.

Risks

• The value of the grant is subject to market volatility and the company's future stock performance.
• Vesting is contingent upon the director's continued service through June 2027, posing a minor retention risk.

Future Outlook

The granted units will vest in full in June 2027, assuming continued board service, which aligns management's long-term incentives with company performance and shareholder value.

Management Comments

• Restricted stock units vest in full on June 2, 2027, subject to continued service as a director.

Industry Context

StockSavvy.ai notes that agilon health's use of equity grants for directors is a standard practice in the healthcare sector to ensure board stability and alignment with long-term shareholder value, particularly following structural changes like a reverse split.

Comparison to Industry Standards

• The RSU grant size is consistent with mid-cap healthcare services director compensation packages.
• The 1-for-25 reverse split is a more aggressive consolidation than the typical 1-for-5 or 1-for-10 splits seen in the S&P 500, often indicating a significant effort to reset the equity structure.

Corporate Governance

Related Party Transactions

• The grant of equity to a director is a standard related party transaction disclosed under SEC rules.

Stakeholder Impact

• Shareholders may see this as a sign of continued commitment from an experienced director.
• The reverse split previously impacted the total number of shares held by all investors, and this filing confirms the adjusted ownership levels.

Next Steps

• Vesting of RSUs on June 2, 2027.

Key Dates

Recommendation

This is a routine insider transaction that does not signal a change in company fundamentals; investors should maintain their current positions pending more significant financial catalysts or earnings reports.

Keywords

agilon health, AGL, Insider Trading, Restricted Stock Units, Director Compensation, Reverse Stock Split, Healthcare Services